179 related articles for article (PubMed ID: 25010778)
21. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
22. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
[TBL] [Abstract][Full Text] [Related]
23. Open-closed motion of Mint2 regulates APP metabolism.
Xie X; Yan X; Wang Z; Zhou H; Diao W; Zhou W; Long J; Shen Y
J Mol Cell Biol; 2013 Feb; 5(1):48-56. PubMed ID: 22730553
[TBL] [Abstract][Full Text] [Related]
24. [Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases].
Mal'tsev AV; Galzitskaia OV
Biomed Khim; 2010; 56(6):624-38. PubMed ID: 21395066
[TBL] [Abstract][Full Text] [Related]
25. Plasma membrane injury depends on bilayer lipid composition in Alzheimer's disease.
Evangelisti E; Zampagni M; Cascella R; Becatti M; Fiorillo C; Caselli A; Bagnoli S; Nacmias B; Cecchi C
J Alzheimers Dis; 2014; 41(1):289-300. PubMed ID: 24614900
[TBL] [Abstract][Full Text] [Related]
26. Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study.
Lemkul JA; Bevan DR
Biochemistry; 2013 Jul; 52(29):4971-80. PubMed ID: 23855340
[TBL] [Abstract][Full Text] [Related]
27. Modeling the Cu+ binding in the 1-16 region of the amyloid-β peptide involved in Alzheimer's disease.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2010 Nov; 114(46):15119-33. PubMed ID: 21038888
[TBL] [Abstract][Full Text] [Related]
28. A commonly used Drosophila model of Alzheimer's disease generates an aberrant species of amyloid-β with an additional N-terminal glutamine residue.
Allan K; Perez KA; Barnham KJ; Camakaris J; Burke R
FEBS Lett; 2014 Oct; 588(20):3739-43. PubMed ID: 25171862
[TBL] [Abstract][Full Text] [Related]
29. Structural origin of polymorphism of Alzheimer's amyloid β-fibrils.
Agopian A; Guo Z
Biochem J; 2012 Oct; 447(1):43-50. PubMed ID: 22823461
[TBL] [Abstract][Full Text] [Related]
30. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
Cheng X; Wu J; Geng M; Xiong J
Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
[TBL] [Abstract][Full Text] [Related]
31. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease.
Mori H; Ishii K; Tomiyama T; Furiya Y; Sahara N; Asano S; Endo N; Shirasawa T; Takio K
Tohoku J Exp Med; 1994 Nov; 174(3):251-62. PubMed ID: 7761990
[TBL] [Abstract][Full Text] [Related]
32. Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies.
O'Malley TT; Oktaviani NA; Zhang D; Lomakin A; O'Nuallain B; Linse S; Benedek GB; Rowan MJ; Mulder FA; Walsh DM
Biochem J; 2014 Aug; 461(3):413-26. PubMed ID: 24785004
[TBL] [Abstract][Full Text] [Related]
33. N-terminal truncated amyloid beta-peptides and Alzheimer's disease.
Larner AJ
Neurobiol Aging; 2001; 22(3):343, 345. PubMed ID: 11414252
[No Abstract] [Full Text] [Related]
34. Endo- and exocytic budding transformation of slow-diffusing membrane domains induced by Alzheimer's amyloid beta.
Morita M; Hamada T; Vestergaard MC; Takagi M
Phys Chem Chem Phys; 2014 May; 16(19):8773-7. PubMed ID: 24676499
[TBL] [Abstract][Full Text] [Related]
35. A β-hairpin-binding protein for three different disease-related amyloidogenic proteins.
Shaykhalishahi H; Mirecka EA; Gauhar A; Grüning CS; Willbold D; Härd T; Stoldt M; Hoyer W
Chembiochem; 2015 Feb; 16(3):411-4. PubMed ID: 25557164
[TBL] [Abstract][Full Text] [Related]
36. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin.
Janciauskiene S; Eriksson S; Wright HT
Nat Struct Biol; 1996 Aug; 3(8):668-71. PubMed ID: 8756322
[No Abstract] [Full Text] [Related]
37. Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible?
Naylor R; Hill AF; Barnham KJ
Eur Biophys J; 2008 Mar; 37(3):265-8. PubMed ID: 18064449
[TBL] [Abstract][Full Text] [Related]
38. Amorphous Aggregation of Amyloid Beta 1-40 Peptide in Confined Space.
Foschi G; Albonetti C; Liscio F; Milita S; Greco P; Biscarini F
Chemphyschem; 2015 Nov; 16(16):3379-84. PubMed ID: 26342212
[TBL] [Abstract][Full Text] [Related]
39. Preliminary studies on trigonelline as potential anti-Alzheimer disease agent: determination by hydrophilic interaction liquid chromatography and modeling of interactions with beta-amyloid.
Makowska J; Szczesny D; Lichucka A; Giełdoń A; Chmurzyński L; Kaliszan R
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 968():101-4. PubMed ID: 24374010
[TBL] [Abstract][Full Text] [Related]
40. Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity.
Cappai R; Barnham KJ
Neurochem Res; 2008 Mar; 33(3):526-32. PubMed ID: 17762917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
